The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Ecosystem Development and Pharma; listed stages are Series A and Series B.

Shane Reiser (Founder and President) and Joanne Fedeyko (VP Mentorship & Commercialization) are listed as the contacts to pitch at Startup Genome.

Across the known portfolio, 3 co-investors appear alongside Startup Genome, including Ariel Savannah Angel Partners, Accelerator Ventures and Cowtown Angels.

Frequently asked questions

What is Startup Genome?

Startup Genome is an accelerator based in San Francisco, California, United States, with a known portfolio of one company. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Startup Genome invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Ecosystem Development and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Startup Genome invest at?

Startup Genome is listed for Series A and Series B rounds in the database. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Startup Genome?

Both people on file at Startup Genome are listed as contacts for the firm, each with their own profile page.

How do I contact Startup Genome?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 2 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal